Lutz D
Int J Clin Pharmacol Ther Toxicol. 1983 Mar;21(3):118-29.
During the last decade immunotherapy for human cancer has been investigated in a remarkable number of clinical trials. To date, no significant advantage has been found compared to other forms of cancer treatment. However, promising results of recent trials require further confirmation. Knowledge of immunotherapeutic modalities, dosages and timing for an effective treatment, as well as criteria of the patients' condition remain unsolved.
在过去十年中,针对人类癌症的免疫疗法已在大量临床试验中得到研究。迄今为止,与其他形式的癌症治疗相比,尚未发现显著优势。然而,近期试验的有前景结果需要进一步证实。关于有效治疗的免疫治疗方式、剂量和时机的知识,以及患者病情标准仍未解决。